A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Sponsor: Eli Lilly and Company • ClinicalTrials.gov ID: NCT07589608
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to examine the body weight-lowering efficacy and safety of macupatide plus eloralintide compared with placebo in participants with obesity or overweight and without type 2 diabetes. Participation will last about 64 weeks.
Interventions
-
Macupatide
(Drug)
Administered SC
-
Eloralintide
(Drug)
Administered SC
-
Placebo
(Drug)
Administered SC
Eligibility criteria
Conditions
Locations
- The Institute for Liver Health II dba Arizona Clinical Trials - Mesa — Chandler, Arizona, United States
- Headlands Research - Scottsdale — Scottsdale, Arizona, United States
- The Institute for Liver Health II dba Arizona Liver Health-Tucson — Tucson, Arizona, United States
- NorCal Medical Research, Inc — Greenbrae, California, United States
- Velocity Clinical Research, Huntington Park — Huntington Park, California, United States
- Peninsula Research Associates — Rolling Hills Estates, California, United States
- Diablo Clinical Research, Inc. — Walnut Creek, California, United States
- Stamford Therapeutics Consortium — Stamford, Connecticut, United States
- New Horizon Research Center — Miami, Florida, United States
- Indago Research & Health Center, Inc — Miami Lakes, Florida, United States
- Suncoast Clinical Research, Inc. — New Port Richey, Florida, United States
- Charter Research - Winter Park — Orlando, Florida, United States
- Charter Research - Lady Lake — The Villages, Florida, United States
- Medical Research Partners — Ammon, Idaho, United States
- Great Lakes Clinical Trials - Ravenswood — Chicago, Illinois, United States
- Cotton O'Neil Diabetes & Endocrinology — Topeka, Kansas, United States
- Monroe Biomedical Research - Louisville — Louisville, Kentucky, United States
- Knownwell — Needham, Massachusetts, United States
- Lucida Clinical Trials — New Bedford, Massachusetts, United States
- Headlands Research - Detroit — Southfield, Michigan, United States
- Arcturus Healthcare , PLC, Troy Internal Medicine Research Division — Troy, Michigan, United States
- StudyMetrix Research — City of Saint Peters, Missouri, United States
- Clinvest Headlands Llc — Springfield, Missouri, United States
- Las Vegas Medical Research — Las Vegas, Nevada, United States
- Dent Neurologic Institute — Amherst, New York, United States
- Rochester Clinical Research, LLC — Rochester, New York, United States
- Medication Management — Greensboro, North Carolina, United States
- Monroe Biomedical Research — Monroe, North Carolina, United States
- Lucas Research, Inc — Morehead City, North Carolina, United States
- Lucas Research, Inc. — New Bern, North Carolina, United States
- CTI Clinical Research Center — Cincinnati, Ohio, United States
- Tribe Clinical Research, LLC — Greenville, South Carolina, United States
- Quality Medical Research — Nashville, Tennessee, United States
- IMA Clinical Research Austin — Austin, Texas, United States
- FutureSearch Trials of Dallas — Dallas, Texas, United States
- PlanIt Research, PLLC — Houston, Texas, United States
- Endeavor Clinical Trials — San Antonio, Texas, United States
- Texas Valley Clinical Research — Weslaco, Texas, United States
- Sovah Clinical Research-River District — Danville, Virginia, United States
- Central Washington Health Services Association d/b/a Confluence Health — Wenatchee, Washington, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record